Suchergebnisse - "Adamchuk, Hryhoriy"

PubPharm (16)

1

RESILIENT Part 2 : A Randomized, Open-Label Phase III Study of Liposomal Irinotecan Versus Topotecan in Adults With Relapsed Small Cell Lung Cancer

enthalten in: Journal of clinical oncology : official journal of the American Society of Clinical Oncology | 2024

von Spigel, D. | Dowlati, A. | Chen, Y. | +115

2

Neoadjuvant palbociclib plus either giredestrant or anastrozole in oestrogen receptor-positive, HER2-negative, early breast cancer (coopERA Breast Cancer) : an open-label, randomised, controlled, phase 2 study

enthalten in: The Lancet. Oncology | 2023

von Hurvitz, S. | Bardia, A. | Quiroga, V. | +21

CommentIn: Lancet Oncol. 2023 Sep;24(9):947-949. - PMID 37657466

3

Treatment With Adjuvant Abemaciclib Plus Endocrine Therapy in Patients With High-risk Early Breast Cancer Who Received Neoadjuvant Chemotherapy : A Prespecified Analysis of the monarchE Randomized Clinical Trial

enthalten in: JAMA oncology | 2022

von Martin, M. | Hegg, R. | Kim, S. | +20

CommentIn: JAMA Oncol. 2022 Nov 1;8(11):1701. - PMID 36173642

4

Plinabulin and Pegfilgrastim in Combination for the Prevention of Chemotherapy-Induced Neutropenia in Patients with Breast Cancer (PROTECTIVE-2): A Randomized Trial

enthalten in: ResearchSquare.com | 2022

von Blayney, D. | Zhang, Q. | Mohanlal, R. | +9

5

Long-Term Safety and Effectiveness of PF-05280014 (a Trastuzumab Biosimilar) Treatment in Patients with HER2-Positive Metastatic Breast Cancer : Updated Results of a Randomized, Double-Blind Study

enthalten in: BioDrugs : clinical immunotherapeutics, biopharmaceuticals and gene therapy | 2022

von Li, R. | Tokunaga, E. | Adamchuk, H. | +9

6

Efficacy of Plinabulin vs Pegfilgrastim for Prevention of Docetaxel-Induced Neutropenia in Patients With Solid Tumors : A Randomized Clinical Trial

enthalten in: JAMA network open | 2022

von Blayney, D. | Mohanlal, R. | Adamchuk, H. | +7

7

Long-Term Safety and Effectiveness of PF-05280014 (a Trastuzumab Biosimilar) Treatment in Patients with HER2-Positive Metastatic Breast Cancer: Updated Results of a Randomized, Double-Blind Study

enthalten in: BioDrugs | 2022

von Li, R. | Tokunaga, E. | Adamchuk, H. | +9

8

Long-Term Safety and Effectiveness of PF-05280014 (a Trastuzumab Biosimilar) Treatment in Patients with HER2-Positive Metastatic Breast Cancer: Updated Results of a Randomized, Double-Blind Study

enthalten in: BioDrugs | 2022

von Li, R. | Tokunaga, E. | Adamchuk, H. | +9

9

Long-Term Safety and Effectiveness of PF-05280014 (a Trastuzumab Biosimilar) Treatment in Patients with HER2-Positive Metastatic Breast Cancer: Updated Results of a Randomized, Double-Blind Study

enthalten in: BioDrugs | 2022

von Li, R. | Tokunaga, E. | Adamchuk, H. | +9

10

Efficacy, Safety and Immunogenicity of MB02 (Bevacizumab Biosimilar) versus Reference Bevacizumab in Advanced Non-Small Cell Lung Cancer : A Randomized, Double-Blind, Phase III Study (STELLA)

enthalten in: BioDrugs : clinical immunotherapeutics, biopharmaceuticals and gene therapy | 2021

von Trukhin, D. | Poddubskaya, E. | Andric, Z. | +96